phrykt

Merck & Co., Inc. (MRK): who owns it and who trades it

As of Nov 16, 2026, MRK insiders reported 34 open-market sales worth $79.3M and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Jennifer Zachary (Vice president), with $25.2M. 11 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Merck

From the latest filings

Overall: about as much buying as selling. Insiders mostly sold. Famous investors mostly bought. Funds and Congress were close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns MRK

3,806 funds and institutions reported MRK shares worth $254B at the end of Q2 2026, about 80% of the company. The largest holder is BlackRock, Inc. with 9.2%.

Funds and institutions (13F) 80%Everyone else 20%

10 largest owners, by share of the company

BlackRock, Inc.9.2%
Vanguard Capital Management LLC6.5%
State Street Corp4.9%
Wellington Management Group LLP3.5%
Vanguard Portfolio Management LLC2.7%
Geode Capital Management, LLC2.5%
Charles Schwab Investment Management Inc2.2%
Morgan Stanley2.0%
FMR LLC (Fidelity)1.8%
JPMorgan Chase & Co1.8%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.227.00M9.19%$29.2B+1%
Vanguard Capital Management LLC161.32M6.53%$20.7B+0%
State Street Corp120.41M4.88%$15.6B+1%
Wellington Management Group LLP86.25M3.49%$11.1B+2%
Vanguard Portfolio Management LLC67.74M2.74%$8.7B+1%
Geode Capital Management, LLC60.74M2.46%$7.8B+2%
Charles Schwab Investment Management Inc54.37M2.20%$7B+9%
Morgan Stanley48.64M1.97%$6.3B+2%
FMR LLC (Fidelity)45.44M1.84%$5.8B+2%
JPMorgan Chase & Co43.89M1.78%$5.7B–
Fisher Asset Management, LLC38.52M1.56%$4.9B+46%
Norges Bank36.98M1.50%$4.8B–
Bank of America Corp30.54M1.24%$3.9B-1%
Northern Trust Corp26.28M1.06%$3.4B-3%
Goldman Sachs Group Inc22.08M0.89%$2.8B+10%
Franklin Resources Inc19.55M0.79%$2.5B+20%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC19.55M0.79%$2.5B-4%
Legal & General Group Plc18.87M0.76%$2.4B-3%
Invesco Ltd.18.61M0.75%$2.4B-15%
T. Rowe Price Associates18.52M0.75%$2.4B-20%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, MRK insiders reported $0 of open-market purchases and $79.3M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$79.3M
34 trades, 10 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Nov 12, 2026
Filed Nov 16, 2026

Purchases and sales by month

$40.7M$40.7MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Nov 12, 2026Richard R. DeLucaVice presidentSale58,185$148.01$8.6MForm 4
Aug 13, 2026Chirfi GuindoVice presidentSale10,000$135.00$1.4MForm 4
Aug 12, 2026Jennifer ZacharyVice presidentSale80,315$133.46$10.7MForm 4
Aug 12, 2026Richard R. DeLucaVice presidentSale11,099$131.61$1.5MForm 4
Aug 12, 2026Richard R. DeLucaVice presidentSale600$132.04$79.2KForm 4
Aug 11, 2026Richard R. DeLucaVice presidentSale7,410$131.33$973KForm 4
Aug 11, 2026Richard R. DeLucaVice presidentSale5,427$132.35$718KForm 4
Aug 10, 2026Richard R. DeLucaVice presidentSale20,784$130.43$2.7MForm 4
Aug 6, 2026Richard R. DeLucaVice presidentSale805$131.02$105KForm 4
Aug 6, 2026Richard R. DeLucaVice presidentSale300$131.02$39.3KForm 4
Aug 6, 2026Richard R. DeLucaVice presidentSale4,945$130.23$644KForm 4
Aug 6, 2026Chirfi GuindoVice presidentSale15,000$131.00$2MForm 4
Aug 5, 2026David R. MaraldoVice presidentSale9,709$128.72$1.2MForm 4
Aug 5, 2026David R. MaraldoVice presidentSale2,686$128.72$346KForm 4
Aug 5, 2026David R. MaraldoVice presidentSale6,311$128.72$812KForm 4
Aug 5, 2026David Michael WilliamsVice presidentSale34,705$128.77$4.5MForm 4
Aug 5, 2026David Michael WilliamsVice presidentSale4,600$128.77$592KForm 4
Aug 5, 2026David Michael WilliamsVice presidentSale13,542$128.77$1.7MForm 4
Feb 12, 2026Chirfi GuindoChief Marketing OfficerSale10,000$121.46$1.2MForm 4
Feb 10, 2026Dean Y LiVice presidentSale10,235$117.52$1.2MForm 4
Feb 9, 2026Chirfi GuindoChief Marketing OfficerSale10,000$118.41$1.2MForm 4
Feb 9, 2026Jennifer ZacharyVice presidentSale38,835$119.15$4.6MForm 4
Feb 9, 2026Jennifer ZacharyVice presidentSale56,792$119.15$6.8MForm 4
Feb 9, 2026Jennifer ZacharyVice presidentSale25,946$119.15$3.1MForm 4
Feb 6, 2026David Michael WilliamsVice presidentSale5,000$121.91$610KForm 4
Feb 6, 2026Johannes Jacobus OosthuizenPresidentSale15,000$121.87$1.8MForm 4
Feb 6, 2026Richard R. DeLucaVice presidentSale37,685$120.92$4.6MForm 4
Feb 5, 2026Chirfi GuindoChief Marketing OfficerSale20,000$121.88$2.4MForm 4
Feb 4, 2026Dalton E. Smart IIIVice presidentSale2,400$119.68$287KForm 4
Feb 4, 2026Dalton E. Smart IIIVice presidentSale4,000$119.68$479KForm 4
Feb 4, 2026Caroline LitchfieldCFOSale41,997$119.61$5MForm 4
Feb 4, 2026Dean Y LiVice presidentSale15,087$118.77$1.8MForm 4
Feb 4, 2026Robert M DavisCEOSale14,972$117.38$1.8MForm 4
Feb 4, 2026Robert M DavisCEOSale32,462$118.35$3.8MForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Jennifer ZacharyEVP, General Counsel–$25.2MAug 12, 2026
Richard R. DeLucaEVP&Pres, Merck Animal Heallth–$19.9MNov 12, 2026
Chirfi GuindoChief Marketing Officer–$8.2MAug 13, 2026
David Michael WilliamsEVP,Chief Info&Digital Officer–$7.4MAug 5, 2026
Robert M DavisChairman, CEO & President, Director–$5.6MFeb 4, 2026
Caroline LitchfieldEVP & CFO–$5MFeb 4, 2026
Dean Y LiExecutive VP & President, MRL–$3MFeb 10, 2026
David R. MaraldoEVP & Pres. MMD–$2.4MAug 5, 2026
Johannes Jacobus OosthuizenPresident, U.S. Market–$1.8MFeb 6, 2026
Dalton E. Smart IIISVP Fin. - Global Controller–$766KFeb 4, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

MRK short interest

Low short interest. 1.1% of MRK shares are sold short: about 1 share in 93. Over the last 12 reports the number of shares short went down 8%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 26.60M MRK shares were sold short, 1.1% of the shares outstanding, down 0.8% from the report before. At the average daily volume of 11.29M shares, buying them all back would take about 2.4 trading days (days to cover).

Shares short, % of all shares

1.08%May 15Oct 301.46%

Days to cover

2.4May 15Oct 304.5

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202626.60M1.08%-1%11.29M2.4
Oct 15, 202626.83M1.09%-5%9.02M3.0
Sep 30, 202628.27M1.15%-18%11.19M2.5
Sep 15, 202634.43M1.40%+14%8.14M4.2
Aug 31, 202630.29M1.23%+24%13.56M2.2
Aug 14, 202624.51M0.99%-13%8.64M2.8
Jul 31, 202628.28M1.15%-4%8.70M3.2
Jul 15, 202629.36M1.19%-6%8.58M3.4
Jun 30, 202631.38M1.27%+4%13.65M2.3
Jun 15, 202630.27M1.23%-1%11.78M2.6
May 29, 202630.55M1.24%+5%9.99M3.1
May 15, 202629.06M1.18%+11%8.01M3.6

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Members of Congress who traded MRK

Since Nov 17, 2024, 17 members of Congress reported 16 purchases and 22 sales of MRK. The latest was a sale by Maria Elvira Salazar on Sep 24, 2026, reported Oct 7, 2026.

Purchases 16Sales 22

Reported trades

Trade dateMemberTypeAmountOwnerReportedSource
Sep 24, 2026Maria Elvira Salazar (R-FL)Partial sale$1K–$15KSelfOct 7, 2026Report
Aug 19, 2026Maria Elvira Salazar (R-FL)Purchase$15K–$50KSelfSep 9, 2026Report
Mar 27, 2026Alan Armstrong (R-OK)Sale$15K–$50KSelfJul 21, 2026Report
Feb 4, 2026Josh Gottheimer (D-NJ)Purchase$1K–$15KJointMar 16, 2026Report
Dec 19, 2025Gilbert Ray Cisneros, Jr. (D-CA)Purchase$1K–$15KSelfJan 12, 2026Report
Dec 18, 2025Julie Johnson (D-TX)Sale$1K–$15KJointJan 15, 2026Report
Nov 18, 2025Gilbert Ray Cisneros, Jr. (D-CA)Purchase$1K–$15KSelfDec 15, 2025Report
Nov 13, 2025Julie Johnson (D-TX)Partial sale$1K–$15KJointDec 11, 2025Report
Sep 23, 2025Val T. Hoyle (D-OR)Sale$1K–$15KSpouseOct 10, 2025Report
Aug 28, 2025Marjorie Greene (GA)Purchase$1K–$15KSelfAug 29, 2025Report
Aug 14, 2025Julie Johnson (D-TX)Partial sale$1K–$15KJointSep 11, 2025Report
Aug 5, 2025Gilbert Ray Cisneros, Jr. (D-CA)Purchase$1K–$15KSelfSep 12, 2025Report
Aug 4, 2025Lisa C. McClain (R-MI)Sale$1K–$15KSpouseSep 12, 2025Report
Jul 11, 2025Ritchie Torres (D-NY)Sale$1K–$15KSelfAug 20, 2025Report
Jun 24, 2025Lisa C. McClain (R-MI)Purchase$1K–$15KSpouseAug 13, 2025Report
Jun 16, 2025Scott Franklin (R-FL)Sale$1K–$15KJointJul 14, 2025Report
Jun 13, 2025Julie Johnson (D-TX)Purchase$1K–$15KJointJul 14, 2025Report
May 30, 2025Gilbert Ray Cisneros, Jr. (D-CA)Sale$1K–$15KSelfJun 6, 2025Report
May 15, 2025Robert P. Bresnahan, Jr. (R-PA)Sale$15K–$50KSelfMay 31, 2025Report
May 5, 2025Marjorie Greene (GA)Purchase$1K–$15KSelfMay 6, 2025Report
Apr 29, 2025Gilbert Ray Cisneros, Jr. (D-CA)Purchase$1K–$15KSelfMay 6, 2025Report
Apr 21, 2025Bruce Westerman (R-AR)Sale$1K–$15KSelfMay 12, 2025Report
Apr 17, 2025Jefferson Shreve (R-IN)Sale$15K–$50KSelfMay 8, 2025Report
Apr 9, 2025Marjorie Greene (GA)Purchase$1K–$15KSelfApr 11, 2025Report
Apr 8, 2025Robert P. Bresnahan, Jr. (R-PA)Purchase$15K–$50KSelfMay 8, 2025Report
Mar 31, 2025Gilbert Ray Cisneros, Jr. (D-CA)Partial sale$15K–$50KSelfApr 7, 2025Report
Mar 20, 2025Kelly Morrison (D-MN)Partial sale$1K–$15KSelfApr 11, 2025Report
Mar 19, 2025Sheri Biggs (R-SC)Sale$15K–$50KSpouseOct 5, 2025Report
Mar 3, 2025Bruce Westerman (R-AR)Purchase$1K–$15KSelfApr 16, 2025Report
Feb 26, 2025Gilbert Ray Cisneros, Jr. (D-CA)Purchase$15K–$50KSelfMar 6, 2025Report
Feb 25, 2025Robert P. Bresnahan, Jr. (R-PA)Sale$15K–$50KSelfMar 27, 2025Report
Feb 24, 2025Jefferson Shreve (R-IN)Purchase$15K–$50KSelfMar 9, 2025Report
Jan 27, 2025Josh Gottheimer (D-NJ)Sale$15K–$50KJointFeb 10, 2025Report
Jan 24, 2025Gilbert Ray Cisneros, Jr. (D-CA)Sale$1K–$15KSelfFeb 11, 2025Report
Jan 17, 2025Julie Johnson (D-TX)Purchase$1K–$15KJointFeb 12, 2025Report
Jan 16, 2025Byron Donalds (R-FL)Sale$1K–$15KSelfFeb 10, 2025Report
Jan 16, 2025Byron Donalds (R-FL)Sale$1K–$15KSpouseFeb 10, 2025Report
Jan 15, 2025Jared Moskowitz (D-FL)Sale$1K–$15KChildFeb 10, 2025Report

Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work

Merck company events

Merck filed 8 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Oct 29, 2026.

  1. Oct 29, 2026ResultsReleased financial results. Filing
  2. Oct 13, 2026LeadershipIncorporated by reference is a press release issued by Merck & Co., Inc. on October 13, 2026, attached as Exhibit 99.1, announcing the election of Paul J. Diaz to the Company’s Board of Directors, effective November 1, 2026. Filing
  3. Aug 4, 2026ResultsReleased financial results. Filing
  4. May 28, 2026VoteReported shareholder vote results. Filing
  5. May 22, 2026AnnouncementMerck & Co., Inc. closed an underwritten public offering of $500 million of Floating Rate Notes due 2028, $1 billion of 4.300% Notes due 2028, $500 million of 4.650% Notes due 2031, $1 billion of 4.950% Notes due 2033, $1.5 billion of 5.200% Notes due 2036, $500 million of 5.750% Notes due 2046 and… Filing
  6. Apr 30, 2026ResultsReleased financial results. Filing
  7. Feb 3, 2026ResultsReleased financial results. Filing
  8. Dec 4, 2025AnnouncementMerck & Co., Inc. closed an underwritten public offering of $500 million of Floating Rate Notes due 2029, $750 million of 3.850% Notes due 2029, $1 billion of 4.150% Notes due 2031, $1 billion of 4.450% Notes due 2032, $1.5 billion of 4.750% Notes due 2035, $750 million of 5.500% Notes due 2046… Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

How Merck makes money

Pharmaceutical brought in 90% of Merck's revenue ($58.1B of $64.5B) in 2025. Animal health was next, at 10%.

By business segment, 2025

Pharmaceutical$58.1B · 90%
Animal health$6.4B · 10%

By region, 2025

United States$36.5B · 57%
Europe, Middle East and Africa$14.6B · 23%
Latin America$3.4B · 5%
Asia Pacific$3B · 5%
Other Countries$2.9B · 4%
Japan$2.7B · 4%
China$1.9B · 3%

From Merck's annual report (10-K) for the year ended Dec 31, 2025, filed Feb 24, 2026. The company chooses how to group its revenue, so the parts differ from one company to the next. Read the filing · How the biggest companies make money

Merck financials

Famous investors that hold MRK

11 of the 50 well-known investors we track reported holding MRK in their latest 13F filing. The largest position is Ken Fisher's, worth $6.1B.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Ken Fisher · Fisher Asset ManagementQ3 202641.70M$6.1B1.7%+8%
Jeremy Grantham · GMOQ3 20265.02M$730M1.6%-26%
Bill Nygren · Harris Associates (Oakmark)Q3 20264.64M$675M0.9%-62%
Ken Griffin · Citadel AdvisorsQ3 20263.32M$483M0.3%+72%
Israel Englander · Millennium ManagementQ3 20261.74M$253M0.2%+211%
Steve Cohen · Point72 Asset ManagementQ3 20261.13M$164M0.3%+196%
Paul Tudor Jones · Tudor Investment CorpQ3 2026422,770$61.4M0.3%New
Prem Watsa · Fairfax Financial HoldingsQ3 2026172,900$25.1M0.9%No change
Ray Dalio · Bridgewater AssociatesQ3 202639,293$5.7M0.0%+30%
Jim Simons · Renaissance TechnologiesQ3 20264,357$633K0.0%New
Tom Russo · Gardner Russo & QuinnQ3 20261,643$239K0.0%+0%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about Merck & Co., Inc. (MRK) stock

Who owns the most MRK stock?

The largest reported owner of Merck & Co., Inc. (MRK) is BlackRock, Inc., with 9.2% of the company. In total, 3,806 funds and institutions reported holding MRK at the end of Q2 2026, together about 80% of the shares. See the largest owners.

Are MRK insiders buying or selling?

In the last 12 months, MRK insiders reported no open-market purchases and 34 sales worth $79.3M. The latest trade was on Nov 12, 2026. See every trade.

What is the short interest in MRK?

As of Oct 30, 2026, 26.60M MRK shares were sold short, 1.1% of the shares outstanding, down 0.8% from the report before. At the average daily volume of 11.29M shares, buying them all back would take about 2.4 trading days (days to cover). See the history.

Have members of Congress traded MRK?

Yes. 17 members of Congress reported 16 purchases and 22 sales of MRK since Nov 17, 2024. The latest was reported on Oct 7, 2026. See the trades.

How does Merck make money?

Pharmaceutical brought in 90% of Merck's revenue ($58.1B of $64.5B) in 2025. Animal health was next, at 10%. See the full split.

Which famous investors hold MRK?

11 of the 50 well-known investors we track reported MRK in their latest 13F filing, including Ken Fisher, Jeremy Grantham, Bill Nygren. The largest position is worth $6.1B. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.